Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Healthcare provider perspectives on diagnosing and treating adults with attention-deficit/hyperactivity disorder.

Adler LA, Farahbakhshian S, Romero B, Flood E, Doll H.

Postgrad Med. 2019 Aug 1:1-12. doi: 10.1080/00325481.2019.1647080. [Epub ahead of print]

PMID:
31340712
2.

A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction.

Truebel H, Wuester S, Boehme P, Doll H, Schmiedl S, Szymanski J, Langer T, Ostermann T, Cysarz D, Thuermann P.

Eur J Appl Physiol. 2019 May;119(5):1253-1260. doi: 10.1007/s00421-019-04116-7. Epub 2019 Mar 8.

PMID:
30850876
3.

THE GERMAN DOSE RATE MONITORING NETWORK AND IMPLEMENTED DATA HARMONIZATION TECHNIQUES.

Stöhlker U, Bleher M, Doll H, Dombrowski H, Harms W, Hellmann I, Luff R, Prommer B, Seifert S, Weiler F.

Radiat Prot Dosimetry. 2019 Jun 1;183(4):404-416. doi: 10.1093/rpd/ncy154.

4.

Evaluation of the Measurement Properties of Four Performance Outcome Measures in Patients with Elective Hip Replacements, Elective Knee Replacements, or Hip Fractures.

Doll H, Gentile B, Bush EN, Ballinger R.

Value Health. 2018 Sep;21(9):1104-1114. doi: 10.1016/j.jval.2018.02.006. Epub 2018 Apr 12.

5.

Health-Related Quality of Life and Work Productivity of Adults With ADHD: A U.K. Web-Based Cross-Sectional Survey.

Joseph A, Kosmas CE, Patel C, Doll H, Asherson P.

J Atten Disord. 2018 Sep 14:1087054718799367. doi: 10.1177/1087054718799367. [Epub ahead of print]

PMID:
30215265
6.

Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences.

Svedsater H, Doll HA, Macey J, Miles G, Bradshaw L, Vanya M.

Adv Ther. 2018 Sep;35(9):1378-1399. doi: 10.1007/s12325-018-0760-7. Epub 2018 Aug 13.

7.

Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension.

Davies EW, Llewellyn S, Beaudet A, Kosmas CE, Gin-Sing W, Doll HA.

Patient Prefer Adherence. 2018 Jun 21;12:1079-1088. doi: 10.2147/PPA.S160662. eCollection 2018.

8.

Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium.

Byrom B, Watson C, Doll H, Coons SJ, Eremenco S, Ballinger R, Mc Carthy M, Crescioni M, O'Donohoe P, Howry C; ePRO Consortium.

Value Health. 2018 Jun;21(6):631-639. doi: 10.1016/j.jval.2017.09.012. Epub 2017 Nov 7. Review.

9.

Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device: Results of a Randomized Equivalence Trial.

Byrom B, Doll H, Muehlhausen W, Flood E, Cassedy C, McDowell B, Sohn J, Hogan K, Belmont R, Skerritt B, McCarthy M.

Value Health. 2018 May;21(5):581-589. doi: 10.1016/j.jval.2017.10.008. Epub 2017 Nov 14.

10.

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire.

Robson JC, Dawson J, Doll H, Cronholm PF, Milman N, Kellom K, Ashdown S, Easley E, Gebhart D, Lanier G, Mills J, Peck J, Luqmani RA, Shea J, Tomasson G, Merkel PA.

Ann Rheum Dis. 2018 Aug;77(8):1157-1164. doi: 10.1136/annrheumdis-2017-212713. Epub 2018 Apr 25.

PMID:
29695498
11.

Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.

Svedsater H, Leather D, Robinson T, Doll H, Nafees B, Bradshaw L.

Respir Med. 2017 Nov;132:76-83. doi: 10.1016/j.rmed.2017.09.010. Epub 2017 Sep 27.

12.

Assessing Therapist Competence: Development of a Performance-Based Measure and Its Comparison With a Web-Based Measure.

Cooper Z, Doll H, Bailey-Straebler S, Bohn K, de Vries D, Murphy R, O'Connor ME, Fairburn CG.

JMIR Ment Health. 2017 Oct 31;4(4):e51. doi: 10.2196/mental.7704.

13.

Early discharge hospital at home.

Gonçalves-Bradley DC, Iliffe S, Doll HA, Broad J, Gladman J, Langhorne P, Richards SH, Shepperd S.

Cochrane Database Syst Rev. 2017 Jun 26;6:CD000356. doi: 10.1002/14651858.CD000356.pub4. Review.

14.

A comparison of the Oxford shoulder score and shoulder pain and disability index: factor structure in the context of a large randomized controlled trial.

Dawson J, Harris KK, Doll H, Fitzpatrick R, Carr A.

Patient Relat Outcome Meas. 2016 Nov 21;7:195-203. eCollection 2016.

15.

Admission avoidance hospital at home.

Shepperd S, Iliffe S, Doll HA, Clarke MJ, Kalra L, Wilson AD, Gonçalves-Bradley DC.

Cochrane Database Syst Rev. 2016 Sep 1;9:CD007491. doi: 10.1002/14651858.CD007491.pub2. Review.

16.

Comment on: delay to diagnosis in axial spondyloarthritis: are we improving in the UK?: Reply.

Sykes M, Doll H, Sengupta R, Gaffney K.

Rheumatology (Oxford). 2016 Sep;55(9):1707-8. doi: 10.1093/rheumatology/kew181. Epub 2016 Jul 19. No abstract available.

PMID:
27436002
17.

The caregiver burden in lupus: findings from UNVEIL, a national online lupus survey in the United States.

Al Sawah S, Daly RP, Foster SA, Naegeli AN, Benjamin K, Doll H, Bond G, Moshkovich O, Alarcón GS.

Lupus. 2017 Jan;26(1):54-61. Epub 2016 May 28.

PMID:
27235701
18.
19.

Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013.

Muehlhausen W, Doll H, Quadri N, Fordham B, O'Donohoe P, Dogar N, Wild DJ.

Health Qual Life Outcomes. 2015 Oct 7;13:167. doi: 10.1186/s12955-015-0362-x. Review.

20.

Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?

Sykes MP, Doll H, Sengupta R, Gaffney K.

Rheumatology (Oxford). 2015 Dec;54(12):2283-4. doi: 10.1093/rheumatology/kev288. Epub 2015 Aug 17. No abstract available.

PMID:
26283680
21.

A RCT of telehealth for COPD patient's quality of life: the whole system demonstrator evaluation.

Rixon L, Hirani SP, Cartwright M, Beynon M, Doll H, Steventon A, Henderson C, Newman SP.

Clin Respir J. 2017 Jul;11(4):459-469. doi: 10.1111/crj.12359. Epub 2015 Sep 17.

PMID:
26260325
22.

The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology.

Anderson RT, Keating KN, Doll HA, Camacho F.

Oncologist. 2015 Jul;20(7):831-8. doi: 10.1634/theoncologist.2014-0219. Epub 2015 Jun 17.

23.

Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis? A Randomized Control Trial.

Yates M, Hamilton LE, Elender F, Dean L, Doll H, MacGregor AJ, Thomas J, Gaffney K.

J Rheumatol. 2015 Jul;42(7):1177-85. doi: 10.3899/jrheum.141335. Epub 2015 Jun 1.

PMID:
26034151
24.

A transdiagnostic comparison of enhanced cognitive behaviour therapy (CBT-E) and interpersonal psychotherapy in the treatment of eating disorders.

Fairburn CG, Bailey-Straebler S, Basden S, Doll HA, Jones R, Murphy R, O'Connor ME, Cooper Z.

Behav Res Ther. 2015 Jul;70:64-71. doi: 10.1016/j.brat.2015.04.010. Epub 2015 Apr 22.

25.

The Reliability and Validity of the Clinical Perfectionism Questionnaire in Eating Disorder and Community Samples.

Egan SJ, Shafran R, Lee M, Fairburn CG, Cooper Z, Doll HA, Palmer RL, Watson HJ.

Behav Cogn Psychother. 2016 Jan;44(1):79-91. doi: 10.1017/S1352465814000629. Epub 2015 Mar 3.

26.

The development of an online measure of therapist competence.

Cooper Z, Doll H, Bailey-Straebler S, Kluczniok D, Murphy R, O'Connor ME, Fairburn CG.

Behav Res Ther. 2015 Jan;64:43-8. doi: 10.1016/j.brat.2014.11.007. Epub 2014 Nov 26.

27.

Meaningful changes for the Oxford hip and knee scores after joint replacement surgery.

Beard DJ, Harris K, Dawson J, Doll H, Murray DW, Carr AJ, Price AJ.

J Clin Epidemiol. 2015 Jan;68(1):73-9. doi: 10.1016/j.jclinepi.2014.08.009. Epub 2014 Oct 31.

28.

Development and validation of a parent-report measure for detection of cognitive delay in infancy.

Schafer G, Genesoni L, Boden G, Doll H, Jones RAK, Gray R, Adams E, Jefferson R.

Dev Med Child Neurol. 2014 Dec;56(12):1194-1201. doi: 10.1111/dmcn.12565. Epub 2014 Sep 23.

29.

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.

Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, Jayne D, Mahr A, Westman K, Luqmani R.

Rheumatology (Oxford). 2015 Mar;54(3):471-81. doi: 10.1093/rheumatology/keu366. Epub 2014 Sep 8.

PMID:
25205825
30.

Change in health status in long-term conditions over a one year period: a cohort survey using patient-reported outcome measures.

Peters M, Crocker H, Dummett S, Jenkinson C, Doll H, Fitzpatrick R.

Health Qual Life Outcomes. 2014 Aug 12;12:123. doi: 10.1186/s12955-014-0123-2.

31.

Effect of telehealth on glycaemic control: analysis of patients with type 2 diabetes in the Whole Systems Demonstrator cluster randomised trial.

Steventon A, Bardsley M, Doll H, Tuckey E, Newman SP.

BMC Health Serv Res. 2014 Aug 6;14:334. doi: 10.1186/1472-6963-14-334.

32.

Cost-effectiveness of telecare for people with social care needs: the Whole Systems Demonstrator cluster randomised trial.

Henderson C, Knapp M, Fernández JL, Beecham J, Hirani SP, Beynon M, Cartwright M, Rixon L, Doll H, Bower P, Steventon A, Rogers A, Fitzpatrick R, Barlow J, Bardsley M, Newman SP.

Age Ageing. 2014 Nov;43(6):794-800. doi: 10.1093/ageing/afu067. Epub 2014 Jun 20.

33.

Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physical function.

Nixon A, Kerr C, Doll H, Naegeli AN, Shingler SL, Breheny K, Burge R, Gold DT, Silverman S.

Osteoporos Int. 2014 Jun;25(6):1775-84. doi: 10.1007/s00198-014-2695-4. Epub 2014 Apr 16.

34.

Comment on: 'Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry' by Sørensen et al.

Sykes M, Doll H, Gaffney K.

Ann Rheum Dis. 2014 Jul;73(7):e44. doi: 10.1136/annrheumdis-2014-205589. Epub 2014 Apr 7. No abstract available.

PMID:
24709862
35.

Minimally important change was estimated for the Manchester-Oxford Foot Questionnaire after foot/ankle surgery.

Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C.

J Clin Epidemiol. 2014 Jun;67(6):697-705. doi: 10.1016/j.jclinepi.2014.01.003. Epub 2014 Apr 5.

PMID:
24709030
36.

INTERCAL: long-term inter-comparison experiment for dose rate and spectrometric probes.

Bleher M, Doll H, Harms W, Stöhlker U.

Radiat Prot Dosimetry. 2014 Aug;160(4):306-10. doi: 10.1093/rpd/ncu039. Epub 2014 Mar 16.

PMID:
24639590
37.

The routine collection of patient-reported outcome measures (PROMs) for long-term conditions in primary care: a cohort survey.

Peters M, Crocker H, Jenkinson C, Doll H, Fitzpatrick R.

BMJ Open. 2014 Feb 21;4(2):e003968. doi: 10.1136/bmjopen-2013-003968.

38.

The effect of telecare on the quality of life and psychological well-being of elderly recipients of social care over a 12-month period: the Whole Systems Demonstrator cluster randomised trial.

Hirani SP, Beynon M, Cartwright M, Rixon L, Doll H, Henderson C, Bardsley M, Steventon A, Knapp M, Rogers A, Bower P, Sanders C, Fitzpatrick R, Hendy J, Newman SP.

Age Ageing. 2014 May;43(3):334-41. doi: 10.1093/ageing/aft185. Epub 2013 Dec 12.

PMID:
24333802
39.

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Robson J, Doll H, Suppiah R, Flossmann O, Harper L, Höglund P, Jayne D, Mahr A, Westman K, Luqmani R.

Ann Rheum Dis. 2015 Jan;74(1):177-84. doi: 10.1136/annrheumdis-2013-203927. Epub 2013 Nov 15.

PMID:
24243925
40.

Utilizing novel diversity estimators to quantify multiple dimensions of microbial biodiversity across domains.

Doll HM, Armitage DW, Daly RA, Emerson JB, Goltsman DS, Yelton AP, Kerekes J, Firestone MK, Potts MD.

BMC Microbiol. 2013 Nov 15;13:259. doi: 10.1186/1471-2180-13-259.

41.

Impact of telehealth on general practice contacts: findings from the whole systems demonstrator cluster randomised trial.

Bardsley M, Steventon A, Doll H.

BMC Health Serv Res. 2013 Oct 8;13:395. doi: 10.1186/1472-6963-13-395.

42.

Inpatient cognitive behaviour therapy for anorexia nervosa: a randomized controlled trial.

Dalle Grave R, Calugi S, Conti M, Doll H, Fairburn CG.

Psychother Psychosom. 2013;82(6):390-8. doi: 10.1159/000350058. Epub 2013 Sep 20.

43.

Total or Partial Knee Arthroplasty Trial - TOPKAT: study protocol for a randomised controlled trial.

Beard D, Price A, Cook J, Fitzpatrick R, Carr A, Campbell M, Doll H, Campbell H, Arden N, Cooper C, Davies L, Murray D.

Trials. 2013 Sep 12;14:292. doi: 10.1186/1745-6215-14-292.

44.

Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.

Peters M, Jenkinson C, Doll H, Playford ED, Fitzpatrick R.

Health Qual Life Outcomes. 2013 Jun 25;11:103. doi: 10.1186/1477-7525-11-103.

45.

The Manchester-Oxford Foot Questionnaire (MOXFQ): Development and validation of a summary index score.

Morley D, Jenkinson C, Doll H, Lavis G, Sharp R, Cooke P, Dawson J.

Bone Joint Res. 2013 Apr 3;2(4):66-9. doi: 10.1302/2046-3758.24.2000147. Print 2013.

46.

Can pain and function be distinguished in the Oxford Knee Score in a meaningful way? An exploratory and confirmatory factor analysis.

Harris K, Dawson J, Doll H, Field RE, Murray DW, Fitzpatrick R, Jenkinson C, Price AJ, Beard DJ.

Qual Life Res. 2013 Nov;22(9):2561-8. doi: 10.1007/s11136-013-0393-x. Epub 2013 Mar 23.

PMID:
23526094
47.

Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.

Henderson C, Knapp M, Fernández JL, Beecham J, Hirani SP, Cartwright M, Rixon L, Beynon M, Rogers A, Bower P, Doll H, Fitzpatrick R, Steventon A, Bardsley M, Hendy J, Newman SP; Whole System Demonstrator evaluation team.

BMJ. 2013 Mar 20;346:f1035. doi: 10.1136/bmj.f1035. Erratum in: BMJ. 2013;346:j2065.

48.

Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial.

Cartwright M, Hirani SP, Rixon L, Beynon M, Doll H, Bower P, Bardsley M, Steventon A, Knapp M, Henderson C, Rogers A, Sanders C, Fitzpatrick R, Barlow J, Newman SP; Whole Systems Demonstrator Evaluation Team.

BMJ. 2013 Feb 26;346:f653. doi: 10.1136/bmj.f653.

49.

Effect of telecare on use of health and social care services: findings from the Whole Systems Demonstrator cluster randomised trial.

Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Beynon M, Hirani S, Cartwright M, Rixon L, Knapp M, Henderson C, Rogers A, Hendy J, Fitzpatrick R, Newman S.

Age Ageing. 2013 Jul;42(4):501-8. doi: 10.1093/ageing/aft008. Epub 2013 Feb 25.

50.

Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.

Peters M, Fitzpatrick R, Doll H, Playford ED, Jenkinson C.

J Health Serv Res Policy. 2013 Jan;18(1):28-33. doi: 10.1258/jhsrp.2012.011176.

PMID:
23393039

Supplemental Content

Support Center